A prospective real-world analysis of erenumab in refractory chronic migraine

BACKGROUND: Clinical trials have shown the safety and clinical superiority of erenumab compared to placebo in chronic migraine (CM). The aim of this analysis is to evaluate the effectiveness and tolerability of erenumab in a real-world setting in patients with refractory CM. METHODS: This is a prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambru, Giorgio, Hill, Bethany, Murphy, Madeleine, Tylova, Ivona, Andreou, Anna P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268737/
https://www.ncbi.nlm.nih.gov/pubmed/32487102
http://dx.doi.org/10.1186/s10194-020-01127-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268737/
https://www.ncbi.nlm.nih.gov/pubmed/32487102
http://dx.doi.org/10.1186/s10194-020-01127-0

Ejemplares similares